Use of calcitonin in osteoarthritis

Details for Australian Patent Application No. 2008202879 (hide)

Owner Novartis AG Nordic Bioscience A/S

Inventors Azria, Moise; Christiansen, Claus; Bateman, Simon David; Li, Shoufeng

Agent Davies Collison Cave

Pub. Number AU-B-2008202879

Parent 2004262906

Filing date 30 June 2008

Wipo publication date 24 July 2008

Acceptance publication date 24 May 2012

International Classifications

A61K 38/23 (2006.01) Medicinal preparations containing peptides - Calcitonins

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 47/16 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing nitrogen

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61P 19/08 (2006.01) Drugs for skeletal disorders

Event Publications

17 July 2008 Complete Application Filed

24 July 2008 Application Open to Public Inspection

  Published as AU-B-2008202879

24 May 2012 Application Accepted

  Published as AU-B-2008202879

20 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008202880-Pharmaceutical compositions containg water-soluble prodrugs of propofol and methods of administering same

2008202878-Cradled sensor assembly